MJHS

MJHS
Moldovan Journal of Health Sciences

Navigation
Journal Navigation
Article Navigation
opened article
Volum 13, Issue 2
June 2026
Cover Image

Article contents

<Anterior Următor>
opened journal
Volum 13, Issue 2
June 2026
Cover Image
Journals article Research

Correlation between inflammatory hematological indices with severity of pulmonary thromboembolism

Doina Ranga1*, Cornelia Talmaci1, Sergiu Matcovschi1, Natalia Caproș1, Livi Grib2, Andrei Cealan3
https://doi.org/10.52645/MJHS.2026.2.02

Manuscript received: 09.03.2025

Accepted for publication: 21.05.2026

Published: 15.06.2026

PDF XML
Doina Ranga1*, Cornelia Talmaci1, Sergiu Matcovschi1, Natalia Caproș1, Livi Grib2, Andrei Cealan3 . Correlation between inflammatory hematological indices with severity of pulmonary thromboembolism. Mold J Health Sci. 2026;2(13):10-14.https://doi.org/10.52645/MJHS.2026.2.02

Abstract

Introduction

Pulmonary thromboembolism (PTE) is a major cardiovascular emergency associated with significant mortality. Systemic inflammation contributes to the pathogenesis of thrombosis and to disease severity, and hematological indices derived from the complete blood count, such as the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), have been proposed as prognostic predictors. 

Materials and methods

A prospective observational study was conducted on a cohort of 182 consecutively investigated patients at Holy Trinity Municipal Clinical Hospital and the Institute of Cardiology. The diagnosis of PTE was confirmed by CT pulmonary angiography. Clinical data, inflammatory hematological indices, echocardiographic parameters, and severity scores were analyzed during the course of inpatient care. The prognostic value of NLR and PLR was assessed using ROC curve analysis.

Results

Pulmonary thromboembolism was confirmed in 153 patients (84.1%, 95% CI [78.7, 89.4]). Elevated NLR was identified in 82 patients (45.1%; 95% CI [37.8, 52.3]), and elevated PLR in 89 patients (48.9%; 95% CI [41.6, 56.2]). Overall mortality was 17.0% (95% CI [11.6, 22.5]) (31 patients). Elevated NLR was present in 26 (14.3; 95% CI [9.2, 19.4]) of deceased patients (p<0.00001), while elevated PLR was present in 22 (12.1%; 95% CI [7.4, 16.8]) of deceased patients (p = 0.012). ROC analysis demonstrated that NLR has a very good predictive ability for mortality (AUC = 0.799), whereas PLR has good predictive ability (AUC = 0.715). Additionally, NLR was significantly correlated with severity according to the PESI score (AUC = 0.614; p = 0.0048). Echocardiography revealed right ventricular dysfunction in 80.2% (95% CI [74.4, 86.0]) of patients and reduced TAPSE in 57.7% (95% CI [50.5, 64.9]) of patients.

Conclusions

The neutrophil-to-lymphocyte ratio is an important prognostic marker of severity and mortality in pulmonary thromboembolism, with a predictive value superior to that of the platelet-to-lymphocyte ratio. Integrating inflammatory hematological indices with clinical scores and imaging assessment may improve risk stratification and the management of patients with pulmonary thromboembolism.

Key Messages

What is not yet known on the issue addressed in the submitted manuscript

Interest in easily accessible inflammatory hematological indices, such as the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), has increased considerably in the evaluation of pulmonary thromboembolism. However, the correlation between these hematological indices and disease severity, as well as their clinical relevance, remains insufficiently clarified, particularly in the population of the Republic of Moldova.

The research hypothesis

Inflammatory hematological indices derived from the complete blood count, namely NLR and PLR, are associated with disease severity and mortality in patients with pulmonary thromboembolism and may serve as prognostic predictors.

The novelty added by the manuscript to the already published scientific literature

This study provides original data on the prognostic value of the hematological indices NLR and PLR in pulmonary thromboembolism and demonstrates their association with disease severity and mortality, which remain insufficiently investigated in the population of the Republic of Moldova.

Introduction

Pulmonary thromboembolism (PTE) is a major cardiovascular condition associated with high mortality, particularly in patients with hemodynamic instability [1]. Systemic inflammation plays a key role in the pathogenesis of thrombosis and disease progression, and inflammatory hematological indices derived from the complete blood count, such as the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), have been identified as predictors of disease severity and mortality [2], although evidence for PLR remains limited, with some studies failing to demonstrate an independent prognostic role [3]. The purpose of the study was to evaluate the correlation of NLR and PLR with CT pulmonary angiography findings, echocardiographic parameters, Pulmonary Embolism Severity Index (PESI) severity score, and mortality in patients with pulmonary thromboembolism.

Material and methods

This prospective observational study was conducted on a cohort of 182 consecutive patients admitted with clinical suspicion of PTE to two hospital institutions between 2021 and 2025: Holy Trinity Municipal Clinical Hospital and the Institute of Cardiology.

Participant Selection. The study included adult patients (≥18 years) with clinical suspicion of acute PTE. The diagnosis was confirmed by CT pulmonary angiography (CTPA), which is considered the standard of care for this condition and allows exclusion of relevant differential diagnoses [1, 4]. 

For each patient, demographic data (age, sex), clinical presentation at admission, comorbidities, laboratory parameters, and imaging findings were collected. Laboratory analyses included a complete blood count, from which the NLR and PLR were calculated, as well as D-dimer and NT-proBNP levels,Wells score, revised Geneva score. All patients underwent echocardiographic evaluation, including assessment of right ventricular function parameters such as right ventricular diameter and tricuspid annular plane systolic excursion (TAPSE), and TAPSE/PSAP index. Disease severity was assessed using the Pulmonary Embolism Severity Index (PESI) score. Patients were followed up for clinical outcomes and mortality during the course of inpatient care. Exclusion criteria were: patients with symptoms attributable to other acute conditions, such as acute or chronic coronary syndrome, dissecting aortic aneurysm, acute abdomen, or acute heart or respiratory failure, as well as patients who used drugs that may affect laboratory parameters (steroids, antibiotics, cytotoxic agents, immunosuppressants, antiplatelet drugs, anticoagulants, epinephrine).

Statistical analysis. Categorical variables were summarized as frequencies and percentages. The predictive value of NLR and PLR for mortality was assessed using Receiver Operating Characteristic (ROC) curve analysis, calculating the area under the curve (AUC), sensitivity, and specificity. A p-value <0.05 was considered statistically significant.

Results

The prospective study included a total of 182 patients with clinical suspicion of PTE, of whom 99 were men (54.4%; 95% CI [47.2, 61.6]) and 83 were women (45.6%; 95% CI [38.4, 52.8]). Age distribution showed a predominance of elderly patients, with the most frequent age group being 60–69 years, comprising 64 cases (35.2%; 95% CI [28.2, 42.1]), followed by the 70–79 years group with 48 patients (26.4%; 95% CI [20.0, 32.8]), 50–59 years with 27 patients (14.8%; 95% CI [9.7, 20.0]), patients over 80 years with 16 cases (8.8%; 95% CI [4.7, 12.9]), 40–49 years with 18 cases (9.9%; 95% CI [5.6, 14.2]), and patients under 40 years, who accounted for 9 cases (4.9%; 95% CI [1.8, 8.1]).

Clinically, dyspnea was the main symptom present in 181 patients (99.5%; 95% CI [98.4, 100]). Other manifestations included cough in 68 patients (37.4%; 95% CI [30.3, 44.4]), fever in 37 patients (20.3%; 95% CI [14.5, 26.2]), syncope or presyncope in 10 patients (5.5%; 95% CI [2.2, 8.8]) and hemoptysis in 4 patients (2.2%; 95% CI [0.1, 4.3]).

Concomitant pathologies were common, the most frequent being angina pectoris in 149 patients (81.9%; 95% CI [76.3, 87.5]), arterial hypertension in 141 patients (77.5%; 95% CI [71.4, 83.5]), pneumonia in 65 patients (35.7%; 95% CI [28.8, 42.7]), arrhythmias in 60 patients (33.0%; 95% CI [26.1, 39.8]), diabetes mellitus in 34 patients (18.7%; 95% CI [13.0, 24.3]), and chronic obstructive pulmonary disease in 32 patients (17.6%; 95% CI [12.1, 23.1]).

Laboratory parameters revealed elevated D-dimer levels in 181 patients (99.5%), increased NT-proBNP in 33.0% of cases (95% CI [26.1, 39.8]), and elevated C-reactive protein in 149 patients (81.9%; 95% CI [76.3, 87.5]). The neutrophil-to-lymphocyte ratio (NLR) was elevated in 82 patients (45.1%; 95% CI [37.8, 52.3]), and the platelet-to-lymphocyte ratio (PLR) was elevated in 89 patients (48.9%; 95% CI [41.6, 56.2]). The overall mortality was 17.0% (95% CI [11.6, 22.5]), corresponding to 31 patients. Among these, 26 patients (14.3%; 95% CI [9.2, 19.4]) had elevated NLR, and 22 patients (12.1%; 95% CI [7.4, 16.8]) had elevated PLR, demonstrating a significant association between inflammatory hematological indices and mortality.

According to the Wells score, intermediate clinical probability was present in 129 patients (70.9%; 95% CI [64.3, 77.5]), and high probability in 52 patients (28.6%; 95% CI [22.0, 35.1]). The revised Geneva score indicated intermediate probability in 118 patients (64.8%; 95% CI [57.9, 71.8]) and high probability in 52 patients (28.6%; 95% CI [22.0, 35.1]). 

Echocardiographic evaluation revealed significant right ventricular alterations. Right ventricular dysfunction was present in 146 patients (80.2%; 95% CI [74.4, 86.0]), and TAPSE was reduced in 105 patients (57.7%; 95% CI [50.5, 64.9]). Assessment of right ventriculo-arterial coupling, expressed as the TAPSE/PASP ratio, showed normal values in 41 patients (22.5%; 95% CI [16.5, 28.6]), mildly reduced values in 44 patients (24.2%; 95% CI [18.0, 30.4]), and reduced values in 97 patients (53.3%; 95% CI [46.0, 60.5]), indicating severe right ventricular dysfunction in more than half of the patients.

The diagnosis of PTE was confirmed by CTPA in 153 patients (84.1%; 95% CI [78.7, 89.4]) while in 29 patients (15.9%; 95% CI [10.6, 21.3]) the diagnosis was not confirmed. 

Fig. 1 Chest and mediastinal CT pulmonary angiography.

Note: After intravenous contrast administration, filling defects are observed in the right middle and lower lobe pulmonary arteries, associated with areas of pulmonary consolidation containing air bronchograms, suggestive of pulmonary infarction with abscess formation on the right. A right-sided pleural effusion with air-fluid levels is also present, consistent with pleural empyema. Pulmonary hypertension is indicated by a pulmonary trunk diameter of 3.2 cm.

Among patients with confirmed PTE (Figure 1), bilateral filling defects were identified in 123 patients (67.6%; 95% CI [60.8, 74.4]), central-peripheral location in 114 patients (62.6%; 95% CI [55.6, 69.7]), peripheral location in 38 patients (20.9%; 95% CI [15.0, 26.8]), involvement of the right pulmonary artery in 22 patients (12.1%; 95% CI [7.4, 16.8]), and the left pulmonary artery in 8 patients (4.4%; 95% CI [1.4, 7.4]). Signs of right ventricular dilatation on CTPA were present in 77 patients (42.3%; 95% CI [35.1, 49.5]).

Fig. 2. ROC curve for NLR predicting mortality.

Note: Receiver operating characteristic (ROC) curve demonstrating the predictive performance of the neutrophil-to-lymphocyte ratio (NLR) for mortality in patients with pulmonary embolism. The area under the curve (AUC) was 0.799. The dashed line represents the line of no discrimination.

ROC curve analysis demonstrated that the neutrophil-to-lymphocyte ratio (NLR) had the highest predictive value for mortality, with an AUC of 0.799, indicating very good prognostic performance (Figure 2).

Fig. 3 ROC curve for PLR predicting mortality.

Note: Receiver operating characteristic (ROC) curve demonstrating the predictive performance of the platelet-to-lymphocyte ratio (PLR) for mortality in patients with pulmonary embolism. The area under the curve (AUC) was 0.715. The dashed line represents the reference line.

The platelet-to-lymphocyte ratio (PLR) showed good predictive value, with an AUC of 0.715 (Figure 3), and NLR correlated with disease severity assessed by the PESI score, with an AUC of 0.614 (Figure 4). 

Fig. 4 ROC curve for NLR predicting severe PESI.

Note: Receiver operating characteristic (ROC) curve showing the predictive value of the neutrophil-to-lymphocyte ratio (NLR) for severe pulmonary embolism assessed by the Pulmonary Embolism Severity Index (PESI). The area under the curve (AUC) was 0.614. The dashed line represents the reference line (line of no discrimination).

Assessment of disease severity using the PESI score showed a predominance of patients with intermediate and high risk, comprising 104 patients (57.1%; 95% CI [50.0, 64.3]).

Discussion

In our study, the diagnosis of pulmonary thromboembolism was confirmed by CT pulmonary angiography, which remains the gold standard for identifying arterial filling defects and assessing disease severity, with high sensitivity and specificity, as previously reported, including in studies conducted at our institution [1].

The results of our study demonstrated that the NLR is an important predictor of mortality in patients with pulmonary thromboembolism, with an AUC of 0.799. These findings are consistent with those reported by Tang et al., who found similar predictive value for NLR, confirming the role of systemic inflammation in disease progression [3]. Elevated NLR reflects activation of the inflammatory response and has been associated with right ventricular dysfunction and poor prognosis, data consistent with the findings of Kowsika R. et al [2].

Elevated NLR in acute PE was associated with a worse short-term and long-term prognosis and with a longer duration of hospitalization in a study by Efros O. et al [5]. In a meta-analysis by Wang Q, was revealed that NLR and PLR are promising biomarkers in predicting prognosis in acute PE patients and recommended NLR and PLR be used routinely in the PE prognostic assessment [6].

Severity assessed by the PESI score correlated with elevated NLR values, confirming the results reported by Teodoru M. et al., who showed that inflammatory hematological indices can improve risk stratification in patients with pulmonary thromboembolism [7].

Conclusions

The neutrophil-to-lymphocyte ratio is an important prognostic marker of severity and mortality in pulmonary thromboembolism, with a predictive value superior to that of the platelet-to-lymphocyte ratio. Integrating inflammatory hematological indices with clinical scores and imaging assessment may improve risk stratification and the management of patients with pulmonary thromboembolism.

Competing interests

None declared.

Authors’ contributions

DR conceived the study design and performed the statistical analysis. CT participated in diagnosing and treating patients with pulmonary thromboembolism. SM critically reviewed the manuscript and contributed to its intellectual content. NC participated in the study design and critically reviewed the manuscript. LG provided clinical expertise and consultation for the management of most patients. CA radiologist, performed CT, pulmonary angiography in the majority of patients. All authors have read and approved the final version of the manuscript.

Ethics approval

The study protocol was reviewed and approved by the Research Ethics Committee of Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, Republic of Moldova (Approval No. 2/25; March 30, 2023). All procedures were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.

Patient consent 

Obtained.

Acknowledgements and funding

No external funding.

Provenance and peer review

Not commissioned, externally peer reviewed.

Authors’ ORCID IDs

Doina Ranga – https://orcid.org/0009-0007-1345-4975

Cornelia Talmaci – https://orcid.org/0000-0002-5603-2277

Sergiu Matcovschi – https://orcid.org/0000-0003-1623-930X

Natalia Caproș – https://orcid.org/0000-0001-7283-8468

Livi Grib – https://orcid.org/0000-0001-6913-0864

Andrei Cealan – https://orcid.org/0000-0001-8478-097X

References 

  1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
  2. Kowsika R, Muthukumaran L, Sridhar R et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as biomarkers for risk stratification and predictors of 90-day mortality in acute pulmonary embolism. South East Eur J Pub Health. 2025;26(Suppl 1):6009-6018.
  3. Tang S, Hu Y. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of mortality in acute pulmonary embolism: a systematic review and meta-analysis. Pak J Med Sci. 2024 Jul;40(6):1274-1279. doi: 10.12669/pjms.40.6.8802.
  4. Ranga D, Caproș N, Cealan A, Sirbu I, Talmaci C, Matcovschi S. Diagnosing pulmonary embolism with computed tomography pulmonary angiography. In: Sontea V, Tiginyanu I, Railean S, editors. IFMBE-2023: 6th International Conference on Nanotechnologies and Biomedical Engineering, 20-23 September 2023, Chişinău, Republic Moldova: Abstract book. Chişinău: Springer; 2024. Vol.92, p. 333-342. ISBN 978-303142781-7. https://doi.org/10.1007/978-3-031-42782-4_36.
  5. Efros O, Beit Halevi T, Meisel E, et al. The prognostic role of neutrophil-to-lymphocyte ratio in patients hospitalized with acute pulmonary embolism. J Clin Med. 2021 Sep 8;10(18):4058. doi: 10.3390/jcm10184058.
  6. Wang Q, Ma J, Jiang Z, Ming L. Et al.  Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis.Int Angiol. 2018 Feb;37(1):4-11. doi: 10.23736/S0392-9590.17.03848-2.
  7. Teodoru M, Negrea MO, Cozgarea A, et al. Enhancing pulmonary embolism mortality risk stratification using machine learning: the role of the neutrophil-to-lymphocyte ratio. J Clin Med. 2024 Feb 20;13(5):1191. doi: 10.3390/jcm13051191.

Email Alerts

Receive exclusive offers and updates
from MJHS

More articles

Research The spectrum of comorbidities in patients with heart failure with preserved ejection fraction
Irina Cabac-Pogorevici, Adriana Scalețchi*, Valeriu Revenco
https://doi.org/10.52645/MJHS.2026.2.01
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases and is frequently associated with cardiovascular and metabolic comorbidities. The phenotype of HFpEF patients is heterogeneous, and the impact of comorbidities on prognosis, exercise capacity, and functional status remains insufficiently elucidated.
Research Impact of COVID-19 on chronic kidney disease progression: a prospective cohort study
Tatiana Răzlog1*, Eugeniu Russu1,2, Costina Groza1, Liliana Groppa2
https://doi.org/10.52645/MJHS.2026.2.04
Chronic kidney disease and COVID-19 are both associated with significant morbidity. Patients with chronic kidney disease are at risk for severe COVID-19, and SARS-CoV-2 infection may accelerate CKD progression. This study aimed to compare renal outcomes in CKD patients with and without prior COVID-19 and to identify predictors of progression.
Research Clinical assessment of risk factors in traumatic brain injury
Natalia Mocanu1,2*, Larisa Rezneac1,2, Natalia Catanoi1,2, Tatiana Malacinschi-Codreanu1,2
https://doi.org/10.52645/MJHS.2026.2.05
Traumatic brain injury remains a leading global health concern with significant social and economic impact. The main causes include traffic accidents, falls, and violence, especially affecting young adults. In the Republic of Moldova, TBI incidence is rising, particularly during the prehospital phase. TBI involves both primary and secondary brain injuries, the latter often resulting from hypoxia, hypotension, or hyperglycemia. These secondary insults critically influence outcomes and are associated with high mortality. Effective prehospital management – focused on stabilizing oxygenation and hemodynamics – is essential in reducing neurological deterioration. Emergency teams play a key role in preventing secondary injury and improving survival.
Research Clinical application of wide and extra-wide archwires in the treatment of dentoalveolar malocclusions
Mihaela Jarovlea-Bejenari1*, Oleg Solomon1, Oleg Arnaut2,3,4
https://doi.org/10.52645/MJHS.2026.2.06
Aesthetic and functional considerations have always been the main concerns in the orthodontic treatment of dentoalveolar malocclusions. The objective of this study was to assess the effectiveness of the use of wide and extra-wide archwires in reducing treatment time, compared with conventional archwire therapy.
Research The influence of stress factors on dioxoindolinone stability
Tatiana Ștefaneț
https://doi.org/10.52645/MJHS.2026.2.07
Stability studies for pharmaceutical products represent a primary stage in the development and manufacture of a new medicinal product, being a fundamental condition that guarantees its quality and efficacy. The research was initiated with the aim of the determining the stability of Dioxoindolinone under stress conditions in order to find out the factors that can induce possible changes in the molecular structure of the Dioxoindolinone, which consequently can lead to a partial or total diminution of the therapeutic effect.
Research Evaluation of oxidant and antioxidant system markers in patients with pulmonary tuberculosis before and after hospital treatment
Marina Reabiseva1*, Valeriana Pantea2, Anatolie Visnevschi1
https://doi.org/10.52645/MJHS.2026.2.03
Pulmonary tuberculosis remains a major cause of morbidity and mortality worldwide. According to data published by the World Health Organization in 2024, a total of 8.2 million people were newly diagnosed with TB in 2023, compared with 7.5 million in 2022, 7.1 million in 2019, and markedly higher than the 5.8 million and 6.4 million in 2020 and 2021, respectively.
Review Proteases involved in distant posttraumatic lesions: a review of literature
Dan Croitoru1,2*, Ion Iachimovschi1, Oleg Arnaut3
https://doi.org/10.52645/MJHS.2026.2.08
Inflammation is a state driven by pathogenic stimuli. Trauma is one of the causes of acute onset of the inflammatory pathway. Multiple proteases are capable of inducing distant multiple organ lesions (lungs, brain or spinal cord, heart, kidney, liver and systemic vessel endothelium). The onset of corresponding syndromes will complicate the clinical course of that particular patient. These molecules are potential biomarkers in trauma patients.
Review Circadian rhythms in cardiovascular physiology and disease: extrinsic and intrinsic factors with implications for intensive care
Iraida Camerzan
https://doi.org/10.52645/MJHS.2026.2.09
Introduction. Circadian rhythms are endogenous, approximately 24-hour oscillations that coordinate nearly all physiological systems, including cardiovascular function. The suprachiasmatic nucleus serves as the central pacemaker, synchronizing peripheral clocks in the heart, vasculature, and kidneys to generate daily fluctuations in blood pressure, heart rate, endothelial function, coagulation, myocardial metabolism, and autonomic tone. Disruption of circadian organization – through extrinsic factors (shift work, irregular light exposure, altered feeding schedules) or intrinsic factors (aging, inflammation, genetic clock-gene variants) – has been strongly linked to increased cardiovascular morbidity and mortality. Material and methods. A bibliographic search was conducted in PubMed, Scopus, and Web of Science for English-language publications (2000–2025), focusing on the circadian rhythm, cardiovascular disease, hypertension, chronotherapy, and critical illness. Keywords included “circadian rhythm,” “cardiovascular disease,” “hypertension,” “chronotherapy,” and “intensive care.” Original research, clinical trials, meta-analyses, and experimental studies were eligible; studies addressing circadian blood pressure variability and its relation to outcomes in critically ill patients were specifically examined. Filters required full-text availability and publication dates from 2000 to 2025. The search yielded 276 full-text articles, of which 79 representative sources were selected for this narrative review. Results. This review synthesizes current evidence demonstrating that circadian clocks regulate essential cardiovascular processes and that their disruption contributes to disease pathogenesis. Observational data on circadian blood pressure variability are discussed, showing that the attenuation of normal hemodynamic oscillations is associated with a worse prognosis. Particular attention is given to the extrinsic and intrinsic factors that modulate circadian alignment, with implications for the management of patients in intensive care.
Review Epilepsy-specific quality-of-life questionnaires and social stigma scales in adults with epilepsy: a methodological review
Gabriela Lișinschi-Baranov1, Stanislav Groppa2, Larisa Spinei3, Vitalie Ojovan4,5, Vitalie Chiosa2, Alina Ferdohleb3,5*
https://doi.org/10.52645/MJHS.2026.2.10
Adult epilepsy generates a burden that extends beyond seizure counts and includes adverse treatment effects, role restriction, emotional distress, and the social devaluation attached to the diagnosis. The methodological problem is not the absence of patient-reported measures, but the heterogeneity with which disease-specific quality-of-life and stigma instruments are selected, interpreted, and combined in adult studies.
Review Follicular lymphoma and its transformation to diffuse large B-cell lymphoma - a brief introduction to disease biology
Ivan Negara1*, Oleg Arnaut1,2,3, Sanda Buruiana4
https://doi.org/10.52645/MJHS.2026.2.11
Follicular lymphoma (FL) is a slow-growing B-cell lymphoma with a generally favorable prognosis. Nevertheless, its clinical course is heterogeneous, with a significant subset of patients experiencing early progression or histological transformation into diffuse large B-cell lymphoma (DLBCL), both considered to be high-risk events associated with treatment resistance and markedly inferior outcomes. Importantly, clinical risk factors have limited value in predicting these complications. This review outlines the key biologic features of FL, discussing how the novel molecular biology approaches can explain the clinical heterogeneity and high-risk disease evolution of FL.
Review Tick-borne mix infection diagnosis, challenges, and current practices
Olga Sofronie*, Greta Balan
https://doi.org/10.52645/MJHS.2026.2.12
Tick-borne infections (TBIs) are increasingly recognized as a public health concern in North America and Europe, with Lyme disease being the most notable. The Centers for Disease Control and Prevention (CDC) acknowledges that official statistics likely underestimate the true incidence of TBIs due to diagnostic challenges and underreporting. Co-infections, where multiple pathogens are transmitted through a single tick bite or multiple bites, complicate diagnosis and treatment, leading to more severe symptoms and longer illness durations. Studies indicate a significant percentage of Lyme disease patients also have co-infections, with babesiosis being a common co-infection.
Case study Non-immune fetal hydrops and intestinal obstruction: rare manifestations of congenital syphilis
Anastasia Neagu*, Larisa Crivceanscaia
https://doi.org/10.52645/MJHS.2026.2.14
Fetal hydrops is defined as the pathological accumulation of extracellular fluid in at least two fetal anatomical compartments, including skin edema (> 5 mm thickness), pericardial effusion, pleural effusion, and ascites. Non-immune fetal hydrops (NIHF) accounts for over 90% of all fetal hydrops cases and has a heterogeneous etiology. Congenital infections contribute to approximately 6–7% of NIHF cases and are associated with a severe neonatal prognosis.